The future of Indonesia’s picture are drawn by its youth. The substantial factor of basic need such as food is still questionable for Indonesian, so plenty of cultural problems are faced present day. In my opinion, there’s always a chance to change, so it’s not a proper paradigm to place health as “boobling under videos” priority. Without healthy mind, body, and soul, how do the people could grab better achievement ? So, it’s parallel with basic need in abstract paradigm, healthy lifestyle as important as safety and chance to grab better vertical mobility- ie education- for all kind of level. To place healthy- the abstract need- with the concrete basic need- food,clothes, settlement- in the similar box must become a part of first thing first list. It’s a fallacy to place abstract need after concrete need, if we wants to build anew Indonesia, both of it are urgent- important aspect of life.
In more than 30 years since 1967, Indonesia made substantial progress. A period of economic growth was experienced which successfully resulted in raising the per capita income from USD 50 in 1968 to USD 1,124 in 1996. These achievements received a severe set back in mid-1997 when the Indonesian economy collapsed. The value of the currency plummeted, prices increased, and unemployment rose dramatically. In addition, parts of the country suffered from relatively long droughts and extensive forest fires. This sudden crisis resulted in political turmoil and change of government. Although the health status of Indonesians was not affected drastically in the short term, the economic crisis certainly slowed down the development of the health system. The ensuing political instability had a direct impact on economic recover.
Tuberculosis is a major health problem. It is the second highest cause of death and the first killer for infectious diseases. It is estimated that 175,000 people die every year from tuberculosis. The DOTS strategy has been expanded to 225 districts (74.8%) out of a total at 311 districts, covering 88 out of the 210 million people. The health of women and children continues to be a problem. With five million pregnancies every year in Indonesia, more than 20,000 women die annually during pregnancy and delivery. The high number of maternal deaths is especially a problem in rural areas with limited access to delivery by skilled attendants and an inadequate referral system. Almost 50% of women give birth without skilled attendants and 70% have no postpartum care during the six weeks following delivery. Indonesians are increasingly exposed to health risks from environmental hazards. Cases of severe urban air pollution and massive air contamination of ground and surface water resources by industries and households are common. Many potentially harmful chemicals are readily available to the public and are regularly used at places of work in agriculture, industry and commerce. Food contamination of both microbiological and chemical origin is a major issue
Per capita consumption of medicines is relatively small in Indonesia. Indonesia’s per capita consumption of medicines is one third of per capital consumption in Malaysia, the Philippines and Thailand value and 1/9 of consumption per capita in Singapore. With a population of around 220 million consumption of medicines in the country was only US$ 1.8 billion in value or about the same as the consumption value by the Philippines with a population of only 70 million. According to the IMS Health, per capita consumption of medicines in the country averages only US$ 6-8 a year as against US$ 15 in Malaysia or US$ 58,5 in Singapore.The market potency of Indonesia is the biggest among all, vice versa the number of consumption.
The low consumption is partly attributable to low purchasing power of the consumers. The government, therefore, launched the generic medicine program in 1989 requiring government health installations to use generic medicines. The campaigns to popularize the use of generic medicines has also been launched among the private sector. The success in the program curbed an increase in the price of patent products.
Lately, the health ministry raised the prices of generic medicines. Based on a decision of the health minister No.112/VII/2003, the prices of 153 types of generic medicines were raised by a range of 5% to 50%.In the 1998-2002 period, the market share of generic medicines grew by 41.3% annually on the average. The fast growth showed that demand for generic medicines has continued to increase especially amid the weak purchasing power of the people. The Drug and Food Control Agency (BPOM) has continued to increase supply of generic medicines as the government carries an obligation to meet the medicinal requirement of the people especially low income people.
So, how about the health capitalization? Sounds evil, huh ? Yes, health is so priceless, and also expensive- for some people-, its all about state of mind. We can’t count for healthy need if we don’t know the purchasing level of Indonesian. It’s a fact that healthcare business is a huge industry with vast commodity. Knowing the data of purchasing level will help us to converse the cause and result.
Lets talk ‘bout business now, we can separate the health factor in three stages, to promote, prevent, and cure. Each functional aspect need for specific commodity and off course, there are several big business player with their own portofolio. The low end of Indonesia market segment is dominant. The market character is uneducated with the urge and important of health life, we can compare the cigarette and pharmacy market data below. They can spend for cigarette three three times than drugs. So that low purchasing level is’nt the only factor but also the people’s state of mind ‘bout health itself.
The market size of cure aspect is so crowded, red ocean. The media try to expose phytopharmacy as the next big thing, but I’m not sure with the prediction. The people buy jamu because of their purchasing level, but, if they look for quality of medical treatment, they still rely on conventional ones. The market size of herbs is still dominated by West Europe, mostly by Germany ( 26% ) and and followed by Asia ( not including Japan, 12 %). The future of phytopharmaca will be dominant as food supplement and food additives, to promote and prevent, but not to cure.
So, considering in market state of mind. The players should invest in social aspect, to educate the urge and important of healthy lifestyle. The wash hand and daily tooth-gums health culture campaign i.e. is a brilliant example, to promote aspect product line. The low cost investment will build a bold trust in customer mind. It will need a long time to educate market, but be sure that there will be customer loyalty next time.
Picture taken from here
Data taken from Dataindo Intiswakarsa and various resources
by : Maximillian